查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508660

骨诱导再生市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Guided Bone Regeneration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 302 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于引导骨再生 (GBR) 市场的综合报告。该报告对关键市场动态进行了深入分析，并对影响市场前景的驱动因素、趋势、机会和课题提供了见解。

关键见解

  • 引导骨再生市场规模（2024 年）：7.914 亿美元
  • 预计市值（2033 年）：12 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：4.7%

骨引导再生市场 - 研究范围：

引导骨再生（GBR）技术透过促进局部缺损的骨组织再生，在再生牙科和骨科中发挥重要作用。这些技术使用屏障膜和骨移植材料来创造适合骨骼生长的空间并恢復骨量和结构。 GBR 市场为牙科诊所、医院和骨科中心提供服务，为各种临床应用提供各种生物材料、薄膜和手术器械。

推动市场成长的因素：

全球引导骨再生市场受到多种因素的推动，包括牙周病患病率的增加、创伤和疾病导致的骨缺损发生率的上升以及更容易患骨相关疾病的老龄化人口的增加。因素。生物材料、膜设计和微创手术技术的技术进步正在提高治疗效果和患者康復并推动市场扩张。此外，GBR技术的应用范围从牙科和骨科专业领域扩展到颜面外科和兽医学，正在为市场参与者创造新的成长机会。

市场限制因素：

儘管成长前景广阔，但骨诱导再生医学市场面临治疗成本高、报销范围有限以及生物材料和医疗器材的审批和商业化监管复杂性等问题。严格的监管要求和区域医疗保健政策给製造商和医疗保健提供者带来了合规负担，影响了市场渗透和业务策略。

市场机会：

由于新兴经济体持续的研发活动、策略联盟和不断扩大的医疗基础设施，骨引导再生医学市场提供了巨大的成长机会。生物相容性材料、客製化植体的 3D 列印技术和数位牙科解决方案的创新提高了治疗准确性和患者治疗效果，刺激了市场需求。此外，远距医疗平台和数位医疗技术的整合有利于远距患者监测和术后护理管理，提高治疗依从性和临床结果。

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 蕴藏事项·除外事项

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 开发趋势

第4章 主要内容

  • 产品采用分析:各地区
  • 产品的USP分析
  • 主要的推销策略:各製造厂商
  • 法规情势
  • 大环境分析
  • 波特分析
  • 价值链分析

第5章 市场背景

  • 宏观经济要素
  • 预测要素 - 相关性及影响
  • 市场动态

第6章 COVID-19危机分析

  • 2024年的市场情势
  • COVID-19及影响分析
    • 各材料
    • 各用途
    • 各终端用户
    • 各地区

第7章 全球骨诱导再生市场需求(数量)分析

  • 过去的市场数量分析，2019年～2023年
  • 现在及未来市场数量预测，2024年～2033年
    • 与前一年同期比较成长趋势分析

第8章 全球骨诱导再生市场 - 价格分析

  • 各地区价格分析:各材料
  • 价格的明细
    • 厂商层级
    • 分销商层级
  • 世界平均价格分析基准
  • 价格设定的前提条件

第9章 全球骨诱导再生市场需求(金额或规模，一百万美元)分析

  • 过去的市场金额(一百万美元)分析，2019年～2023年
  • 现在及未来市场金额(一百万美元)预测，2024年～2033年
    • 与前一年同期比较成长趋势分析
    • 绝对额的机会分析

第10章 全球骨诱导再生市场分析:各材料

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)和数量的分析:各材料，2019年～2023年
  • 现在及未来市场规模(一百万美元)和数量的分析与预测:各材料，2024年～2033年
    • 骨移植替代品
    • 阻障薄膜
  • 市场魅力分析:各材料

第11章 全球骨诱导再生市场分析:各用途

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析:各用途，2019年～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测:各用途，2024年～2033年
    • 植入学
    • 牙周病学
    • 口腔外科
    • 其他
  • 市场魅力分析:各用途

第12章 全球骨诱导再生市场分析:各终端用户

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析:各终端用户，2019～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测:各终端用户，2024年～2033年
    • 医院
    • 牙科医院
    • 学术研究中心
    • 门诊病人手术中心
  • 市场魅力分析:各终端用户

第13章 全球骨诱导再生市场分析:各地区

  • 简介
  • 过去的市场规模(一百万美元)和数量的分析:各地区，2019年～2023年
  • 现在及未来市场规模(一百万美元)和数量的分析与预测:各地区，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东·非洲
  • 市场魅力分析:各地区

第14章 北美的骨诱导再生市场分析

第15章 南美的骨诱导再生市场分析

第16章 欧洲的骨诱导再生市场分析

第17章 南亚的骨诱导再生市场分析

第18章 东亚的骨诱导再生市场分析

第19章 大洋洲的骨诱导再生市场分析

第20章 中东·非洲(MEA)的骨诱导再生市场分析

第21章 市场结构分析

  • 市场分析:各级企业
  • 主要企业的市场占有率分析
  • 市场影响分析

第22章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争的详细资讯
    • Baxter International Inc.
    • Medtronic
    • Stryker Corp.
    • Integra LifeSciences
    • Zimmer Biomet Holdings
    • Dentsply Sirona
    • botiss biomaterials GmbH
    • Geistlich Pharma AG
    • Biotech Dental
    • Dentegris GmbH
    • GENOSS Co.,Ltd.
    • Osstem Implant

第23章 所使用的前提条件与缩写

第24章 调查手法

简介目录
Product Code: PMRREP32985

Persistence Market Research has recently released a comprehensive report on the Guided Bone Regeneration (GBR) market. The report provides an in-depth analysis of crucial market dynamics, offering insights into drivers, trends, opportunities, and challenges shaping the market landscape.

Key Insights:

  • Guided Bone Regeneration Market Size (2024E): USD 791.4 million
  • Projected Market Value (2033F): USD 1,200.00 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.7%

Guided Bone Regeneration Market - Report Scope:

Guided Bone Regeneration (GBR) techniques play a critical role in regenerative dentistry and orthopedic surgery by facilitating the regeneration of bone tissue in localized defects. These techniques involve the use of barrier membranes and bone graft materials to create a space conducive to bone growth, thereby restoring bone volume and architecture. The GBR market serves dental clinics, hospitals, and orthopedic centers, offering a variety of biomaterials, membranes, and surgical instruments tailored for different clinical applications.

Market Growth Drivers:

The global Guided Bone Regeneration market is driven by several factors, including increasing prevalence of periodontal diseases, rising incidence of bone defects due to trauma or disease, and growing aging population susceptible to bone-related disorders. Technological advancements in biomaterials, membrane designs, and minimally invasive surgical techniques enhance treatment outcomes and patient recovery, fostering market expansion. Moreover, expanding applications of GBR techniques beyond dental and orthopedic specialties into maxillofacial surgery and veterinary medicine create new growth opportunities for market players.

Market Restraints:

Despite promising growth prospects, the Guided Bone Regeneration market faces challenges related to high treatment costs, limited reimbursement coverage, and regulatory complexities governing the approval and commercialization of biomaterials and medical devices. Stringent regulatory requirements and varying healthcare policies across regions impose compliance burdens on manufacturers and healthcare providers, influencing market penetration and operational strategies.

Market Opportunities:

The Guided Bone Regeneration market presents significant growth opportunities driven by ongoing research and development activities, strategic collaborations, and expanding healthcare infrastructure in emerging economies. Innovations in biocompatible materials, 3D printing technologies for customized implants, and digital dentistry solutions enhance treatment precision and patient outcomes, stimulating market demand. Furthermore, the integration of telemedicine platforms and digital health technologies facilitates remote patient monitoring and post-operative care management, improving treatment adherence and clinical outcomes.

Competitive Intelligence and Business Strategy:

Leading players in the global Guided Bone Regeneration market, such as Medtronic,Stryker Corp.,Integra LifeSciences, focus on product innovation, strategic partnerships, and market expansion initiatives to maintain competitive advantage. These companies invest in R&D to develop advanced biomaterials, biodegradable membranes, and patient-specific surgical kits, addressing diverse clinical needs and enhancing treatment efficacy. Collaborations with academic institutions, dental research centers, and regulatory agencies support technology adoption and market access, driving sustainable growth in the dynamic GBR landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Guided Bone Regeneration market globally?
  • Which biomaterials and membrane technologies are driving adoption of GBR techniques across dental and orthopedic specialties?
  • How are technological advancements reshaping the competitive landscape of the Guided Bone Regeneration market?
  • Who are the key players contributing to the Guided Bone Regeneration market, and what strategies are they employing to sustain market leadership?
  • What are the emerging trends and future prospects in the global Guided Bone Regeneration market?

Key Companies Profiled

  • Baxter International Inc.
  • Medtronic
  • Stryker Corp.
  • Integra LifeSciences
  • Zimmer Biomet Holdings
  • Dentsply Sirona
  • botiss biomaterials GmbH
  • Geistlich Pharma AG
  • Biotech Dental
  • Dentegris GmbH
  • GENOSS Co., Ltd.
  • Osstem Implant

Guided Bone Regeneration Industry Research Segmentation

By Material:

  • Bone Graft Substitutes
  • Barrier Membranes

By Application:

  • Implantology
  • Periodontology
  • Oral and Maxillofacial Surgery

By End User:

  • Hospitals
  • Dental Clinics
  • Academic & Research Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion And Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development Trends

4. Key Inclusions

  • 4.1. Product Adoption Analysis by Region
  • 4.2. Product USP Analysis
  • 4.3. Key Promotional Strategies by Manufacturers
  • 4.4. Regulatory Scenario
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Outlook
    • 5.1.3. Global Bone Regeneration Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Increasing Prevalence of Dental Diseases
    • 5.2.3. Adoption of Minimally Invasive Procedures
    • 5.2.4. Increasing Prevalence of Bone Related disorders
    • 5.2.5. New Product launches and approvals
    • 5.2.6. Regulatory Policies
    • 5.2.7. Historic and Current Revenue of key players
    • 5.2.8. Technology advancements
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Material
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Region

7. Global Guided Bone Regeneration Market Demand (Volume) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Guided Bone Regeneration Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Material
  • 8.2. Pricing Break Up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Guided Bone Regeneration Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Material

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Material, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Material, 2024-2033
    • 10.3.1. Bone Graft Substitutes
      • 10.3.1.1. Allograft
      • 10.3.1.2. Xenograft
      • 10.3.1.3. Synthetic Bone Graft
      • 10.3.1.4. Others
    • 10.3.2. Barrier Membrane
      • 10.3.2.1. Expanded polytetrafluoroethylene (e-PTFE)
      • 10.3.2.2. High-density polytetrafluoroethylene (d-PTFE)
      • 10.3.2.3. Titanium mesh and titanium-reinforced PTFE
  • 10.4. Market Attractiveness Analysis By Material

11. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 11.3.1. Implantology
    • 11.3.2. Periodontology
    • 11.3.3. Oral and Maxillofacial surgery
    • 11.3.4. Others
  • 11.4. Market Attractiveness Analysis By Application

12. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Dental Clinics
    • 12.3.3. Academic & Research Centers
    • 12.3.4. Ambulatory Surgical Centers
  • 12.4. Market Attractiveness Analysis By End User

13. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume ('000 Units)Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa
  • 13.4. Market Attractiveness Analysis By Region

14. North America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Material
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Material
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Guided Bone Regeneration Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Material
        • 14.7.1.2.2. By Application
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Guided Bone Regeneration Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Material
        • 14.7.2.2.2. By Application
        • 14.7.2.2.3. By End User

15. Latin America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Material
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Material
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Guided Bone Regeneration Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Material
        • 15.7.1.2.2. By Application
        • 15.7.1.2.3. By End User
    • 15.7.2. Mexico Portable Multi-Parameter Monitors Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Material
        • 15.7.2.2.2. By Application
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Guided Bone Regeneration Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Material
        • 15.7.3.2.2. By Application
        • 15.7.3.2.3. By End User

16. Europe Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Nordic Countries
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Material
    • 16.3.3. By Portability
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Material
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Guided Bone Regeneration Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Material
        • 16.7.1.2.2. By Application
        • 16.7.1.2.3. By End User
    • 16.7.2. Italy Guided Bone Regeneration Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Material
        • 16.7.2.2.2. By Application
        • 16.7.2.2.3. By End User
    • 16.7.3. France Guided Bone Regeneration Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Material
        • 16.7.3.2.2. By Application
        • 16.7.3.2.3. By End User
    • 16.7.4. U.K. Guided Bone Regeneration Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Material
        • 16.7.4.2.2. By Application
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Guided Bone Regeneration Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Material
        • 16.7.5.2.2. By Application
        • 16.7.5.2.3. By End User
    • 16.7.6. BENULUX Guided Bone Regeneration Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Material
        • 16.7.6.2.2. By Application
        • 16.7.6.2.3. By End User
    • 16.7.7. Russia Guided Bone Regeneration Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Material
        • 16.7.7.2.2. By Application
        • 16.7.7.2.3. By End User
    • 16.7.8. Nordic Countries Guided Bone Regeneration Market
      • 16.7.8.1. Introduction
      • 16.7.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.8.2.1. By Material
        • 16.7.8.2.2. By Application
        • 16.7.8.2.3. By End User

17. South Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Material
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Material
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Guided Bone Regeneration Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Material
        • 17.7.1.2.2. By Application
        • 17.7.1.2.3. By End User
    • 17.7.2. Indonesia Guided Bone Regeneration Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Material
        • 17.7.2.2.2. By Application
        • 17.7.2.2.3. By End User
    • 17.7.3. Malaysia Guided Bone Regeneration Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Material
        • 17.7.3.2.2. By Application
        • 17.7.3.2.3. By End User
    • 17.7.4. Thailand Guided Bone Regeneration Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Material
        • 17.7.4.2.2. By Application
        • 17.7.4.2.3. By End User

18. East Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Material
    • 18.3.3. By Application
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Material
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Guided Bone Regeneration Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Material
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By End User
    • 18.7.2. Japan Guided Bone Regeneration Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Material
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By End User
    • 18.7.3. South Korea Guided Bone Regeneration Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Material
        • 18.7.3.2.2. By Application
        • 18.7.3.2.3. By End User

19. Oceania Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Material
    • 19.3.3. By Application
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Material
    • 19.4.3. By Application
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Guided Bone Regeneration Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Material
        • 19.7.1.2.2. By Application
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Guided Bone Regeneration Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Material
        • 19.7.2.2.2. By Application
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Material
    • 20.3.3. By Application
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Material
    • 20.4.3. By Application
    • 20.4.4. By End User
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Guided Bone Regeneration Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Material
        • 20.7.1.2.2. By Application
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkey Guided Bone Regeneration Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Material
        • 20.7.2.2.2. By Application
        • 20.7.2.2.3. By End User
    • 20.7.3. North Africa Guided Bone Regeneration Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Material
        • 20.7.3.2.2. By Application
        • 20.7.3.2.3. By End User
    • 20.7.4. South Africa Guided Bone Regeneration Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Material
        • 20.7.4.2.2. By Application
        • 20.7.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis
    • 21.3.1. Regional footprint of Players
    • 21.3.2. Material footprint by Players
    • 21.3.3. Channel footprint by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Baxter International Inc.
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Key Developments
      • 22.3.1.7. Strategy Overview
        • 22.3.1.7.1. Channel Strategy
        • 22.3.1.7.2. Marketing Strategy
        • 22.3.1.7.3. Material Strategy
    • 22.3.2. Medtronic
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Key Developments
      • 22.3.2.7. Strategy Overview
        • 22.3.2.7.1. Channel Strategy
        • 22.3.2.7.2. Marketing Strategy
        • 22.3.2.7.3. Material Strategy
    • 22.3.3. Stryker Corp.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Key Developments
      • 22.3.3.7. Strategy Overview
        • 22.3.3.7.1. Channel Strategy
        • 22.3.3.7.2. Marketing Strategy
        • 22.3.3.7.3. Material Strategy
    • 22.3.4. Integra LifeSciences
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Key Developments
      • 22.3.4.7. Strategy Overview
        • 22.3.4.7.1. Channel Strategy
        • 22.3.4.7.2. Marketing Strategy
        • 22.3.4.7.3. Material Strategy
    • 22.3.5. Zimmer Biomet Holdings
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Key Developments
      • 22.3.5.7. Strategy Overview
        • 22.3.5.7.1. Channel Strategy
        • 22.3.5.7.2. Marketing Strategy
        • 22.3.5.7.3. Material Strategy
    • 22.3.6. Dentsply Sirona
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Key Developments
      • 22.3.6.7. Strategy Overview
        • 22.3.6.7.1. Channel Strategy
        • 22.3.6.7.2. Marketing Strategy
        • 22.3.6.7.3. Material Strategy
    • 22.3.7. botiss biomaterials GmbH
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Key Developments
      • 22.3.7.7. Strategy Overview
        • 22.3.7.7.1. Channel Strategy
        • 22.3.7.7.2. Marketing Strategy
        • 22.3.7.7.3. Material Strategy
    • 22.3.8. Geistlich Pharma AG
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Key Developments
      • 22.3.8.7. Strategy Overview
        • 22.3.8.7.1. Channel Strategy
        • 22.3.8.7.2. Marketing Strategy
        • 22.3.8.7.3. Material Strategy
    • 22.3.9. Biotech Dental
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Key Developments
      • 22.3.9.7. Strategy Overview
        • 22.3.9.7.1. Channel Strategy
        • 22.3.9.7.2. Marketing Strategy
        • 22.3.9.7.3. Material Strategy
    • 22.3.10. Dentegris GmbH
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Key Developments
      • 22.3.10.7. Strategy Overview
        • 22.3.10.7.1. Channel Strategy
        • 22.3.10.7.2. Marketing Strategy
        • 22.3.10.7.3. Material Strategy
    • 22.3.11. GENOSS Co.,Ltd.
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Key Developments
      • 22.3.11.7. Strategy Overview
        • 22.3.11.7.1. Channel Strategy
        • 22.3.11.7.2. Marketing Strategy
        • 22.3.11.7.3. Material Strategy
    • 22.3.12. Osstem Implant
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Key Developments
      • 22.3.12.7. Strategy Overview
        • 22.3.12.7.1. Channel Strategy
        • 22.3.12.7.2. Marketing Strategy
        • 22.3.12.7.3. Material Strategy

23. Assumptions and Acronyms Used

24. Research Methodology